Beam Therapeutics (BEAM) Preferred Dividend Payments (2019 - 2020)
Beam Therapeutics' (BEAM) quarterly Preferred Dividend Payments came in at $1.3 million in Q1 2020, down 56.9% year-on-year from $3.0 million in Q2 2019, and down 60.86% on a QoQ basis from $3.3 million in Q4 2019.
Beam Therapeutics (BEAM) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Beam Therapeutics (BEAM) has 2 years of Preferred Dividend Payments data on file, last reported at $1.3 million in Q1 2020.
- On a quarterly basis, Preferred Dividend Payments fell 56.9% year-over-year to $1.3 million in Q1 2020; TTM through Dec 2020 was $1.3 million, a 89.96% decrease from a year earlier, with the FY2020 full-year figure at $1.3 million, down 89.96% from the prior year.
- Preferred Dividend Payments for Q1 2020 stood at $1.3 million, down from $3.3 million in the prior quarter.
- Over the last five years, Preferred Dividend Payments for BEAM reached as high as $3.3 million in Q4 2019 and fell as low as $1.3 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.28 Mn |
| Dec 31, 2019 | 3.26 Mn |
| Sep 30, 2019 | 3.26 Mn |
| Jun 30, 2019 | 3.23 Mn |
| Mar 31, 2019 | 2.96 Mn |